UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Home Office's racism studies before the Macpherson inquiry: Revisiting administrative criminology's corpus

British journal of criminology, 2024-08, Vol.64 (4), p.896-912

Molina, Julian

2024

Volltextzugriff (PDF)

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Mayo Clinic proceedings, 2019-08, Vol.94 (8), p.1623-1640

2019

Volltextzugriff (PDF)

Nancy Luxon (ed.), Archives of Infamy: Foucault on State Power in the Lives of Ordinary Citizens. Minneapolis: University of Minnesota Press, 2019. 400 pp

Foucault studies, 2021-06 (30), p.80-83

Molina, Julian

2021

Volltextzugriff (PDF)

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells

PloS one, 2016-09, Vol.11 (9), p.e0162925

2016

Volltextzugriff (PDF)

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Mayo Clinic proceedings, 2008-05, Vol.83 (5), p.584-594

2008

Volltextzugriff (PDF)

Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors

The American journal of cardiology, 2020-06, Vol.125 (12), p.1920-1926

2020

Volltextzugriff (PDF)

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

The lancet oncology, 2010-10, Vol.11 (10), p.962-972

2010

Volltextzugriff (PDF)

PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM

British journal of cancer, 2022-10, Vol.127 (7), p.1352-1364

2022

Volltextzugriff (PDF)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

JAMA oncology, 2019-07, Vol.5 (7), p.1008

2019

Volltextzugriff (PDF)

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma

Oncogene, 2022-08, Vol.41 (33), p.4003-4017

2022

Volltextzugriff (PDF)

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1540-1550

2016

Volltextzugriff (PDF)

Plasma Biomarkers to Monitor Bronchopulmonary Carcinoids—Are We There Yet?

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.257-259

2023

Volltextzugriff (PDF)

A Preference-Based Evolutionary Algorithm for Multi-Objective Optimization

Evolutionary computation, 2009, Vol.17 (3), p.411-436

2009

Volltextzugriff (PDF)

Immunotherapy in patients with autoimmune disease

Journal of thoracic disease, 2020-11, Vol.12 (11), p.7032-7038

2020

Volltextzugriff (PDF)

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges

Cancers, 2021-12, Vol.14 (1), p.109

2021

Volltextzugriff (PDF)

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma

Human pathology, 2018-09, Vol.79, p.168-176

2018

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2139-2146

2008

Volltextzugriff (PDF)

Intervention Tales: Talk, Documents, and “Engagement” on a Wage Subsidy Project

Qualitative sociology review : QSR, 2018, Vol.14 (1), p.68-82

Molina, Julian

2018

Volltextzugriff (PDF)

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

Frontiers in oncology, 2022-08, Vol.12, p.955440-955440

2022

Volltextzugriff (PDF)

A genetic cell context-dependent role for ZEB1 in lung cancer

Nature communications, 2016-07, Vol.7 (1), p.12231-12231, Article 12231

2016

Volltextzugriff (PDF)

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma

Oncogene, 2023-01, Vol.42 (1), p.79-82

2023

Volltextzugriff (PDF)

Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)

Clinical lung cancer, 2012-07, Vol.13 (4), p.252-266

2012

Volltextzugriff (PDF)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Cell death & disease, 2019-09, Vol.10 (10), p.725-16, Article 725

2019

Volltextzugriff (PDF)

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.96-102

2019

Volltextzugriff (PDF)

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2012-09, Vol.97 (9), p.3179-3184

2012

Volltextzugriff (PDF)

1 – 25 von 1.086

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(900)
Mit Volltextzugriff
(950)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(517)
Life Sciences & Biomedicine
(382)
Humans
(279)
Female
(182)
Male
(180)
Middle Aged
(131)
Oncology
(113)
Aged
(111)
Adult
(105)
Technology
(93)
Computer Science
(71)
Biological And Medical Sciences
(65)
Tumors
(63)
Animals
(59)
Medical Sciences
(54)
Lung Cancer
(51)
Aged, 80 And Over
(48)
Computer Science, Theory & Methods
(48)
Computer Science, Artificial Intelligence
(47)
Patients
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

The Home Office's racism studies before the Macpherson inquiry: Revisiting administrative criminology's corpus

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Nancy Luxon (ed.), Archives of Infamy: Foucault on State Power in the Lives of Ordinary Citizens. Minneapolis: University of Minnesota Press, 2019. 400 pp

Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Plasma Biomarkers to Monitor Bronchopulmonary Carcinoids—Are We There Yet?

A Preference-Based Evolutionary Algorithm for Multi-Objective Optimization

Immunotherapy in patients with autoimmune disease

Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges

BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral, Small-Molecule Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) in Patients With Advanced Cancers

Intervention Tales: Talk, Documents, and “Engagement” on a Wage Subsidy Project

Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis

A genetic cell context-dependent role for ZEB1 in lung cancer

Correction to: PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma

Oncogenic Pathways, Molecularly Targeted Therapies, and Highlighted Clinical Trials in Non–Small-Cell Lung Cancer (NSCLC)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials

A Multiinstitutional Phase 2 Trial of Pazopanib Monotherapy in Advanced Anaplastic Thyroid Cancer

Suchergebnisse filtern